klacid 250mg/5ml granules for oral suspension
mylan ire healthcare limited - clarithromycin - granules for oral suspension - 250 mg/5ml - macrolides; clarithromycin - antibacterial for systemic use, macrolide - it is indicated for the treatment of infections caused by susceptible organisms. indications include: lower respiratory tract infections. upper respiratory tract infections. skin and skin structure infections. acute otitis media.
klacid 250mg film-coated tablets
mylan products limited - clarithromycin - coated tablet - clarithromycin 250 mg - antibacterials for systemic use
klacid 500mg film-coated tablets
mylan products limited - clarithromycin - coated tablet - clarithromycin 500 mg - antibacterials for systemic use
klacid xl 500mg modified-release tablets
mylan products limited - clarithromycin - modified-release tablet - clarithromycin 500 mg - antibacterials for systemic use
klacid mr 500mg tablet
abbott laboratories (m) sdn. bhd. - clarithromycin -
klacid tablet 500mg
abbott laboratories (m) sdn. bhd. - clarithromycin -
klacid 250 mg coated tablets
mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - clarithromycin - coated tablet - clarithromycin 250 mg - antibacterials for systemic use
klacid 500 mg coated tablets
mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - clarithromycin - coated tablet - clarithromycin 500 mg - antibacterials for systemic use
klacid xl modified-release tablets 500mg
mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - clarithromycin - modified-release tablet - clarithromycin 500 mg - antibacterials for systemic use
klacid xl tablet
abbott laboratories s.a. (pty) ltd - tablet - see ingredients - each tablet contains clarithromycin 500,0 mg